Targeted Beta Therapy
Targeted Beta Therapy is a targeted radiopharmaceutical therapy that selectively delivers beta-emitting radionuclides to cancer cells via molecular vectors, enabling localized irradiation while minimizing damage to surrounding healthy tissue.
13
Publications
659
Citations
72
Authors
41
Institutions
Publications per year
2017–2026
7
Variants
Targeted Beta-particle Therapy
13
Gabriel Bodek, Susanna Vierre, Adolfo Rivero‐Müller et al. · Neoplasia · 2005 · 26 citations · Full text
Medicine, Endocrinology, Oncology +17
Alireza Heidari · Journal of Proteomics & Enzymology · 2017 · 25 citations
1–5 of 13
72
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 72
41

Translational Research Institute
Woolloongabba, Australia
1 h-index
8 publications
200 citations

Tel Aviv University
Tel Aviv, Israel
1 h-index
3 publications
60 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 h-index
1 publications
15 citations
Institut de Biologie de Lille
Lille, France
1 h-index
1 publications
378 citations

UNSW Sydney
Sydney, Australia
1 h-index
2 publications
76 citations

Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
1 h-index
2 publications
30 citations
St George Hospital
Sydney, Australia
1 h-index
3 publications
114 citations
Evangelical Theological Faculty
Leuven, Belgium
1 h-index
1 publications
18 citations
1–8 of 41
1 publications · 17 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 26 citations
1
h-index
1–5